These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 954008)

  • 1. The nitrosoureas: an outline of clinical schedules and toxic effects.
    Wasserman TH
    Cancer Treat Rep; 1976 Jun; 60(6):709-11. PubMed ID: 954008
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastrointestinal cancer. Treatment with fluorouracil-nitrosourea combinations.
    Moertel CG
    JAMA; 1976 May; 235(19):2135-6. PubMed ID: 946546
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
    Zackheim HS; Epstein EH
    Arch Dermatol; 1975 Dec; 111(12):1564-70. PubMed ID: 1200661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrosourea chemotherapy for primary malignant gliomas.
    Levin VA; Wilson CB
    Cancer Treat Rep; 1976 Jun; 60(6):719-24. PubMed ID: 954010
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitrosoureas lomustine, carmustine and fotemustine induced hepatotoxic perturbations in rats: biochemical, morphological and flow cytometry studies.
    Laquerriere A; Raguenez-Viotte G; Paraire M; Bizzari JP; Paresy M; Fillastre JP; Hemet J
    Eur J Cancer; 1991; 27(5):630-8. PubMed ID: 1828975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of mechanism of action studies of the nitrosoureas.
    Bono VH
    Cancer Treat Rep; 1976 Jun; 60(6):699-702. PubMed ID: 182364
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system.
    Lohrmann HP; Lepp KA; Schreml W
    J Natl Cancer Inst; 1982 Apr; 68(4):541-7. PubMed ID: 6951071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity of nitrosoureas.
    Schacht RG; Feiner HD; Gallo GR; Lieberman A; Baldwin DS
    Cancer; 1981 Sep; 48(6):1328-34. PubMed ID: 7272960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrosoureas in central nervous system tumors.
    Walker MD
    Cancer Chemother Rep 3; 1973 May; 4(3):21-6. PubMed ID: 4584033
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model.
    Williams PD; Kantor P; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
    Mori KJ; Jasmin C; Hayat M; MacDonald JS; Mathé G
    Cancer Res; 1980 Nov; 40(11):4282-6. PubMed ID: 6451285
    [No Abstract]   [Full Text] [Related]  

  • 12. Formulation of three nitrosoureas for intravenous use.
    Davignon JP; Yang KW; Wood HB; Cradock JC
    Cancer Chemother Rep 3; 1973 May; 4(3):7-11. PubMed ID: 4201309
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicity of very high dose nitrosourea administration.
    Breeden JH; Vollmer JT; Twomey PL
    Cancer; 1982 Nov; 50(9):1728-33. PubMed ID: 7116300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyl-CCNU in malignant melanoma--a divided dose schedule of administration.
    Wittes RE; Hong WK; Gatchell L; Krakoff IH; Golbey RB
    Oncology; 1977; 34(1):45-6. PubMed ID: 865760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study.
    Hoogstraten B; Gottlieb JA; Caoili E; Tucker WG; Talley RW; Haut A
    Cancer; 1973 Jul; 32(1):38-43. PubMed ID: 4716783
    [No Abstract]   [Full Text] [Related]  

  • 16. Alterations in the toxicity and antitumor activity of methyl-CCNU in mice following pretreatment with either phenobarbital or SKF 525A.
    Klubes P; Miller HG; Cerna I; Trevithick J
    Cancer Treat Rep; 1979; 63(11-12):1901-7. PubMed ID: 526922
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cancer chemotherapy with special reference to pharmacokinetics of nitrosoureas].
    Wakui A
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1327-38. PubMed ID: 6223595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sensitivity of colony-forming cells of hemopoietic tissue, Lewis lung carcinoma, and B16 melanoma to three nitrosoureas.
    Blackett NM; Courtenay VD; Mayer SM
    Cancer Chemother Rep; 1975; 59(5):929-33. PubMed ID: 1203897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nitrosourea-induced lung diseases].
    Massin F; Coudert B; Foucher P; Lombard JN; Reybet-Degat O; Jeannin L; Camus P
    Rev Mal Respir; 1992; 9(6):575-82. PubMed ID: 1470749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrosoureas as single agents in the treatment of pulmonary cancer.
    Wolf J
    Cancer Treat Rep; 1976 Jun; 60(6):753-6. PubMed ID: 782697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.